IBULOCK

This brand name is authorized in Nigeria.

Active ingredients

The drug IBULOCK contains one active pharmaceutical ingredient (API):

1	Ibuprofen UNII WK2XYI10QM - IBUPROFEN
	Ibuprofen is a propionic acid derivative NSAID that has demonstrated its efficacy by inhibition of prostaglandin synthesis. In humans ibuprofen reduces inflammatory pain, swellings and fever. Furthermore, ibuprofen reversibly inhibits platelet aggregation.
	Read more about Ibuprofen

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-100626	Tablet	Ibulock 400 Tablets Ibuprofen Tablets TAB 400 mg 10 x 10's (in Alu-PVC blisters)	Tablet 134 NF-PP-374679 IBULOCK 400 TABLETS IBUPROFEN TABLETS 400MG Ibuprofen BP 400MG (Microcrystalline Cellulose, Pregelatinized Starch, Povidone (K-30), Purified Water, Sodium Starch Glycolate, Colloidal Anhydrous Silica, Magnesium Stearate, Purified Talc, Hypromellose, Triacetin, Lactose Monohydrate, Sunset Yellow, Quinoline Yellow, Titanium dioxide) A11-100626 Drugs Nigerian Products 10X10TABLETS OTC 10/17/2023 SHALINA HEALTHCARE NIGERIA LIMITED, 19 Fatai Atere Way, Matori, Mushin 18183973 theophilus.adimoha@shalina.com shalina healthcare Nigeria Limited , Block 3B, Westerner Industrial Avenue, off Lagos-Ibadan Expressway, Isheri, Ifo Local Government Area, Ogun State, Nigeria , Nigeria	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AE01	Ibuprofen	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives
Discover more medicines within M01AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-100626